A detailed history of Cutler Group LP transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Cutler Group LP holds 3,100 shares of DBVT stock, worth $2,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,100
Previous 3,100 -0.0%
Holding current value
$2,480
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 27, 2020

SELL
$1.58 - $4.77 $2,370 - $7,154
-1,500 Reduced 32.61%
3,100 $5,000
Q2 2020

Jul 22, 2020

BUY
$3.74 - $6.28 $12,342 - $20,724
3,300 Added 253.85%
4,600 $20,000
Q1 2020

May 07, 2020

SELL
$2.33 - $12.98 $3,495 - $19,470
-1,500 Reduced 53.57%
1,300 $5,000
Q4 2019

Feb 06, 2020

BUY
$6.75 - $11.15 $3,375 - $5,575
500 Added 21.74%
2,800 $29,000
Q3 2019

Oct 28, 2019

BUY
$8.57 - $10.72 $19,711 - $24,656
2,300 New
2,300 $19,000
Q4 2018

Feb 05, 2019

SELL
$5.75 - $21.85 $8,050 - $30,590
-1,400 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$16.81 - $24.58 $28,576 - $41,786
-1,700 Reduced 54.84%
1,400 $31,000
Q2 2018

Aug 10, 2018

SELL
$18.6 - $24.94 $9,858 - $13,218
-530 Reduced 14.6%
3,100 $59,000
Q1 2018

May 11, 2018

BUY
$20.86 - $26.6 $44,640 - $56,924
2,140 Added 143.62%
3,630 $83,000
Q4 2017

Jan 17, 2018

BUY
$20.9 - $49.36 $31,140 - $73,546
1,490
1,490 $36,000

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $150M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.